Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.

Bo Ahrén, N Adner, J Svartberg, E Petrella, J J Holst, M K Gutniak

Research output: Contribution to journalLetterpeer-review

2 Citations (SciVal)
Original languageEnglish
Pages (from-to)790-792
JournalDiabetic Medicine
Volume19
Issue number9
DOIs
Publication statusPublished - 2002

Subject classification (UKÄ)

  • Endocrinology and Diabetes

Cite this